The findings indicate that two proteins that normally help repair cellular DNA can also destroy the DNA made by HIV after it enters a human cell. This HIV DNA is essential for the virus to survive and reproduce.
The study was led by researchers at The Ohio State University Comprehensive Cancer Center ?Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC ?James) and published in the Proceedings of the National Academy of Sciences.
The findings could lead to a possible new strategy for treating HIV infection and AIDS, one that might complement current therapies and would probably be less susceptible to viral drug resistance ?an increasingly urgent dilemma for patients and doctors.
Currently, doctors treat people with AIDS using combinations of drugs that target the virus itself. These drugs do not eliminate HIV from the body, but they do block its ability to reproduce and spread, and they restore most people with AIDS to good health.
In time, however, HIV can develop mutations that render those drugs ineffective.
"Our findings identify a new potential drug target, one that involves a natural host defense," says principal investigator Richard Fishel, professor of molecular virology, immunology and molecular genetics and a researcher with the OSUCCC ?James. "HIV treatments that target cellular components should be far less likely to develop resistance."
Fishel's laboratory colleague and first author Kristine Yoder discovered the role of the cellular repair proteins while trying to answer a different question.
Before HIV infects a cell, it carries its genetic material in the form of RNA, or ribonucleic acid. Once inside a cell, the virus makes a copy of its genes in the form of DNA. This DNA copy ?known as cDNA ?then travels t
'"/>
Source:Ohio State University